Drug-likeness

Synthesis QSAR (quantitative structure-activity relationship) Characterization Heterocyclic compounds Derivatives Molecular docking Pharmacophore Cytotoxicity binding affinity antimicrobial agents Minimum inhibitory concentration (MIC) Enzyme inhibition In vitro Testing In Vivo Testing Biological Evaluation Lead Optimization Zone of Inhibition Virtual Screening Resistance Structure-Activity Relationship (SAR) Antiviral Activity Enzyme Kinetics Drug Resistance Benzothiazole Drug Repurposing MIC Determination Bioavailability Mycobacterium tuberculosis In Silico Studies Antitubercular Agents Metabolic Stability Antifungal Activity Scaffold Hopping Toxicity Profile Bioisosteres Quinazolinones Docking simulation Gram-positive bacteria Gram-negative bacteria MIC assay Antibacterial spectrum ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) Pharmacokinetics (PK) MTT assay Lipinski’s Rule of Five Docking score Ligand efficiency Selectivity index (SI) MIC90 Tuberculosis (TB)